T 2378/18 of 30.11.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T237818.20211130
- Date of decision
- 30 November 2021
- Case number
- T 2378/18
- Petition for review of
- -
- Application number
- 12197989.2
- IPC class
- G01N 33/574G01N 15/14G01N 1/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Improved methods and devices for cellular analysis
- Applicant name
- Biomarker Strategies, LLC.
- Opponent name
- -
- Board
- 3.4.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 94(3)European Patent Convention R 103(1)(a)European Patent Convention R 112(2)Rules of procedure of the Boards of Appeal 2020 Art 011
- Keywords
- Decision on the state of the file - reasoned (no)
Right to be heard - opportunity to comment (no)
Remittal to the department of first instance
Remittal - (yes)
Reimbursement of appeal fee - (yes) - Catchword
- -
- Cited cases
- T 0278/00T 0963/02T 0265/03T 0897/03T 0583/04T 1182/05T 1356/05T 1360/05T 0750/06T 1612/07T 1614/08T 0591/17T 1922/17
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance for
further prosecution.
3. Reimbursement of the appeal fee in full is ordered.